BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23795707)

  • 1. Distress and the parenting dynamic among BRCA1/2 tested mothers and their partners.
    Mays D; DeMarco TA; Luta G; Peshkin BN; Patenaude AF; Schneider KA; Garber JE; Tercyak KP
    Health Psychol; 2014 Aug; 33(8):765-73. PubMed ID: 23795707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling the dyadic effects of parenting, stress, and coping on parent-child communication in families tested for hereditary breast-ovarian cancer risk.
    Hamilton JG; Mays D; DeMarco T; Tercyak KP
    Fam Cancer; 2016 Oct; 15(4):513-22. PubMed ID: 26848859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parenting through genetic uncertainty: themes in the disclosure of breast cancer risk information to children.
    Sharff ME; DeMarco TA; Mays D; Peshkin BN; Valdimarsdottir HB; Garber JE; Schneider KA; Patenaude AF; Tercyak KP
    Genet Test Mol Biomarkers; 2012 May; 16(5):376-82. PubMed ID: 22085394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Information needs of mothers regarding communicating BRCA1/2 cancer genetic test results to their children.
    Tercyak KP; Peshkin BN; Demarco TA; Patenaude AF; Schneider KA; Garber JE; Valdimarsdottir HB; Schwartz MD
    Genet Test; 2007; 11(3):249-55. PubMed ID: 17949286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not.
    Katapodi MC; Northouse L; Pierce P; Milliron KJ; Liu G; Merajver SD
    Oncol Nurs Forum; 2011 Sep; 38(5):572-81. PubMed ID: 21875844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and correlates of mothers and fathers attending pretest cancer genetic counseling together.
    Demarco TA; Nusbaum RH; Peshkin BN; Patenaude AF; Schneider KA; Garber JE; Valdimarsdottir HB; Tercyak KP
    Patient Educ Couns; 2010 Jan; 78(1):29-33. PubMed ID: 19545972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer-related distress in unselected women with newly diagnosed breast or ovarian cancer undergoing BRCA1/2 testing without pretest genetic counseling.
    Høberg-Vetti H; Eide GE; Siglen E; Listøl W; Haavind MT; Hoogerbrugge N; Bjorvatn C
    Acta Oncol; 2019 Feb; 58(2):175-181. PubMed ID: 30334464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between relationship support and psychological reactions of participants and partners to BRCA1 and BRCA2 testing in a clinic-based sample.
    Manne S; Audrain J; Schwartz M; Main D; Finch C; Lerman C
    Ann Behav Med; 2004 Dec; 28(3):211-25. PubMed ID: 15576260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Family system characteristics and psychological adjustment to cancer susceptibility genetic testing: a prospective study.
    van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; van Gool AR; Klijn JG; Tibben A
    Clin Genet; 2007 Jan; 71(1):35-42. PubMed ID: 17204044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer.
    Schwartz MD; Valdimarsdottir HB; Peshkin BN; Mandelblatt J; Nusbaum R; Huang AT; Chang Y; Graves K; Isaacs C; Wood M; McKinnon W; Garber J; McCormick S; Kinney AY; Luta G; Kelleher S; Leventhal KG; Vegella P; Tong A; King L
    J Clin Oncol; 2014 Mar; 32(7):618-26. PubMed ID: 24449235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.
    van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Tibben A
    Patient Educ Couns; 2007 Jan; 65(1):58-68. PubMed ID: 16872788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRCA1/2 testing in hereditary breast and ovarian cancer families: effectiveness of problem-solving training as a counseling intervention.
    McInerney-Leo A; Biesecker BB; Hadley DW; Kase RG; Giambarresi TR; Johnson E; Lerman C; Struewing JP
    Am J Med Genet A; 2004 Oct; 130A(3):221-7. PubMed ID: 15378542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decisional outcomes of maternal disclosure of BRCA1/2 genetic test results to children.
    Tercyak KP; Mays D; DeMarco TA; Peshkin BN; Valdimarsdottir HB; Schneider KA; Garber JE; Patenaude AF
    Cancer Epidemiol Biomarkers Prev; 2013 Jul; 22(7):1260-6. PubMed ID: 23825307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parents' perception of child behavior, parenting stress, and child abuse potential: Individual and partner influences.
    Miragoli S; Balzarotti S; Camisasca E; Di Blasio P
    Child Abuse Negl; 2018 Oct; 84():146-156. PubMed ID: 30099228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychological issues among children of hereditary breast cancer gene (BRCA1/2) testing participants.
    Tercyak KP; Peshkin BN; Streisand R; Lerman C
    Psychooncology; 2001; 10(4):336-46. PubMed ID: 11462232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brief assessment of parents' attitudes toward testing minor children for hereditary breast/ovarian cancer genes: development and validation of the Pediatric BRCA1/2 Testing Attitudes Scale (P-TAS).
    Peshkin BN; DeMarco TA; Garber JE; Valdimarsdottir HB; Patenaude AF; Schneider KA; Schwartz MD; Tercyak KP
    J Pediatr Psychol; 2009 Jul; 34(6):627-38. PubMed ID: 18385162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
    ; Owens DK; Davidson KW; Krist AH; Barry MJ; Cabana M; Caughey AB; Doubeni CA; Epling JW; Kubik M; Landefeld CS; Mangione CM; Pbert L; Silverstein M; Simon MA; Tseng CW; Wong JB
    JAMA; 2019 Aug; 322(7):652-665. PubMed ID: 31429903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive and emotional factors predicting decisional conflict among high-risk breast cancer survivors who receive uninformative BRCA1/2 results.
    Rini C; O'Neill SC; Valdimarsdottir H; Goldsmith RE; Jandorf L; Brown K; DeMarco TA; Peshkin BN; Schwartz MD
    Health Psychol; 2009 Sep; 28(5):569-578. PubMed ID: 19751083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Young adult daughters of BRCA1/2 positive mothers: what do they know about hereditary cancer and how much do they worry?
    Patenaude AF; Tung N; Ryan PD; Ellisen LW; Hewitt L; Schneider KA; Tercyak KP; Aldridge J; Garber JE
    Psychooncology; 2013 Sep; 22(9):2024-31. PubMed ID: 23417902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect on perceived control and psychological distress of genetic knowledge in women with breast cancer receiving a BRCA1/2 test result.
    Brédart A; Kop JL; De Pauw A; Caron O; Fajac A; Noguès C; Stoppa-Lyonnet D; Dolbeault S
    Breast; 2017 Feb; 31():121-127. PubMed ID: 27837705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.